loader
Please Wait
Applying Filters...
menu
    • menu

    Digital Content for 1-[(2R,4S,5S)-4-azido-5-(hydroxymethyl)oxolan-2-yl]-5-methyl-pyrimidine-2,4-dione

    Client Email Product
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    Bora Pharmaceuticals- Making success more certain.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Virtual Booth

    Contact Supplier

    Axplora- The partner of choice for complex APIs.

    Virtual Booth

    Contact Supplier

    Fareva is a one-stop-shop for API/HPAPI, OSD & Sterile products, is USFDA, EMA and PMDA-inspected and has multiple NDA & ANDA filings.

    Virtual Booth

    Contact Supplier

    Menu

    1-[(2R,4S,5S)-4-azido-5-(hydroxymethyl)oxolan-2-yl]-5-methyl-pyrimidine-2,4-dione

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    PRICE INFORMATION

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    $ API Ref.Price (USD/KG) : 208Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Antiretroviral Therapy's +ve Impact On Global Public Health Faces Challenges
    Antiretroviral Therapy's +ve Impact On Global Public Health Faces Challenges

    12 Aug 2019

    // Joshua Cohen FORBES

    https://www.forbes.com/sites/joshuacohen/2019/08/12/antiretroviral-therapys-positive-impact-on-global-public-health-faces-challenges-moving-forward/#3e2762b32e77

    Joshua Cohen FORBES
    12 Aug 2019
    Share Share
    Pfizer’s Epoetin Alfa Biosimilar Approved by FDA
    Pfizer’s Epoetin Alfa Biosimilar Approved by FDA

    15 May 2018

    // Michael Mezher RAPS

    https://www.raps.org/news-and-articles/news-articles/2018/5/pfizers-epoetin-alfa-biosimilar-approved-by-fda?utm_source=Email&utm_medium=Informz&utm_campaign=Informz-Emails&_zs=VHOsL1&_zl=xpsS4

    Michael Mezher RAPS
    15 May 2018
    Share Share
    A novel approach in mucoadhesive DDS to improve zidovudine intestinal permeblity
    A novel approach in mucoadhesive DDS to improve zidovudine intestinal permeblity

    02 Mar 2017

    // PHARMA EXCIPIENTS

    https://www.pharma-excipients.ch/2017/03/02/a-novel-approach-in-mucoadhesive-drug-delivery-system-to-improve-zidovudine-intestinal-permeability/

    PHARMA EXCIPIENTS
    02 Mar 2017
    Share Share
    Strides Shasun Receives Positive WHO Inspection Report for Formulation Facility
    Strides Shasun Receives Positive WHO Inspection Report for Formulation Facility

    05 Feb 2016

    // TWOFOUR INSIGHT

    http://twofourinsight.com/strides-shasun-receives-positive-who-inspection-report-formulation-facility/

    TWOFOUR INSIGHT
    05 Feb 2016
    Share Share
    Anvisa suspending imports of Chinese inputs
    Anvisa suspending imports of Chinese inputs

    11 Nov 2015

    // ANVISA

    http://portal.anvisa.gov.br/wps/content/anvisa+portal/anvisa/sala+de+imprensa/menu+-+noticias+anos/2015/anvisa++suspende+a+importacao+de+insumos+chineses

    ANVISA
    11 Nov 2015
    Share Share
    American Health Packaging Initiates Class II Recall of Lamivudine and Zidovudine Tablets Due to Failed Dissolution Specifications
    American Health Packaging Initiates Class II Recall of Lamivudine and Zidovudine Tablets Due to Failed Dissolution Specifications

    27 Jun 2015

    // Press Release FDA

    http://www.accessdata.fda.gov/scripts/enforcement/enforce_rpt-Product-Tabs.cfm?action=select&recall_number=D-1140-2015&w=06242015&lang=eng

    Press Release FDA
    27 Jun 2015
    Share Share